These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 9354923)
61. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
62. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171 [TBL] [Abstract][Full Text] [Related]
63. Issues involving biomarkers in the study of the genetics of human cancer. Caporaso N; Goldstein A IARC Sci Publ; 1997; (142):237-50. PubMed ID: 9354923 [TBL] [Abstract][Full Text] [Related]
64. Environmental and chemical carcinogenesis. Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140 [TBL] [Abstract][Full Text] [Related]
65. Genetic susceptibility to cancer. ICRP publication 79. Approved by the Commission in May 1997. International Commission on Radiological Protection. Ann ICRP; 1998; 28(1-2):1-157. PubMed ID: 10406427 [TBL] [Abstract][Full Text] [Related]
66. Gene--environment interactions in the application of biomarkers of cancer susceptibility in epidemiology. Garte S; Zocchetti C; Taioli E IARC Sci Publ; 1997; (142):251-64. PubMed ID: 9354924 [TBL] [Abstract][Full Text] [Related]
67. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies]. Pavanello S; Clonfero E G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438 [TBL] [Abstract][Full Text] [Related]
68. Selection of candidate genes for population studies. Caporaso N IARC Sci Publ; 1999; (148):23-36. PubMed ID: 10493246 [TBL] [Abstract][Full Text] [Related]
69. Health-related disparities: influence of environmental factors. Olden K; White SL Med Clin North Am; 2005 Jul; 89(4):721-38. PubMed ID: 15925646 [TBL] [Abstract][Full Text] [Related]
70. Hereditary common cancers: molecular and clinical genetics. Russo A; Zanna I; Tubiolo C; Migliavacca M; Bazan V; Latteri MA; Tomasino RM; Gebbia N Anticancer Res; 2000; 20(6C):4841-51. PubMed ID: 11205230 [TBL] [Abstract][Full Text] [Related]
71. Relationships between familial risks of cancer and the effects of heritable genes and their SNP variants. Hemminki K; Bermejo JL Mutat Res; 2005 Dec; 592(1-2):6-17. PubMed ID: 15990124 [TBL] [Abstract][Full Text] [Related]
72. Approaches to identify genes for complex human diseases: lessons from Mendelian disorders. Dean M Hum Mutat; 2003 Oct; 22(4):261-74. PubMed ID: 12955713 [TBL] [Abstract][Full Text] [Related]
73. The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Risch N Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):733-41. PubMed ID: 11440958 [TBL] [Abstract][Full Text] [Related]
74. Applications of the concept of attributable fraction in medical genetics. Khoury MJ; Beaty TH; Cohen BH Am J Med Genet; 1991 Aug; 40(2):177-82. PubMed ID: 1832818 [TBL] [Abstract][Full Text] [Related]